Propanc Biopharma, Inc. — Form D
Propanc Biopharma, Inc. of CAMBERWELL, VIC, C3, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-31. The offering totals $73K, of which $73K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-08-31
- Form: D
- Accession: 0001493152-23-031053
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $73K
- Amount sold: $73K
- Minimum investment: $73K
- Investors: 1
- Date of first sale: 2023-08-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-491162
Issuer
- Name: Propanc Biopharma, Inc.
- CIK: 0001517681
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 302, 6 BUTLER STREET, CAMBERWELL, VIC, C3, 3124
- Phone: +61-03-9882-0780
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| James Nathanielsz | Director | Camberwell, VIC, C3 |
| James Nathanielsz | Executive Officer | Camberwell, VIC, C3 |
| Josef Zelinger | Director | Camberwell, VIC, C3 |
| Julian Kenyon | Director | Camberwell, VIC, C3 |
| Julian Kenyon | Executive Officer | Camberwell, VIC, C3 |
| Douglas Mitchell | Director | Powhatan, VA |
| Douglas Mitchell | Executive Officer | Powhatan, VA |
| Carlo Campiciano | Executive Officer | Camberwell, VIC, C3 |
| Julian N Kenyon | Director | Romsey, Hampshire, X0 |
| James A Nathanielsz | Director | Glen Iris, Victoria, C3 |
| James A Nathanielsz | Executive Officer | Glen Iris, Victoria, C3 |
Other filings by this issuer (14)
More